Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
出版年份 2020 全文链接
标题
Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
作者
关键词
-
出版物
ANNALS OF HEMATOLOGY
Volume 99, Issue 7, Pages 1429-1440
出版商
Springer Science and Business Media LLC
发表日期
2020-06-09
DOI
10.1007/s00277-020-04107-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Isavuconazole as Primary Anti-Fungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective, Phase II Study
- (2020) Prithviraj Bose et al. CLINICAL INFECTIOUS DISEASES
- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
- (2019) Hyunkyung Park et al. BMC CANCER
- Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients
- (2019) Lauren Fontana et al. CLINICAL INFECTIOUS DISEASES
- Emerging mould infections: Get prepared to meet unexpected fungi in your patient
- (2019) Sarah Dellière et al. MEDICAL MYCOLOGY
- Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology
- (2019) Oliver A. Cornely et al. MYCOSES
- Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia
- (2019) Taylor M. Weis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Epidemiological aspects and characterization of the resistance profile of Fusarium spp. in patients with invasive fusariosis
- (2019) Priscila Dallé da Rosa et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
- (2019) Huseyin Naci et al. BMJ-British Medical Journal
- Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia
- (2019) Brian T. Fisher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors
- (2019) Swan Lin et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Midostaurin and cyclosporine drug interaction: A case report
- (2019) Robert Mancini et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML
- (2019) Alexander E. Perl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient Selection
- (2019) Hussein A. Abbas et al. Cancer Management and Research
- Azole antifungals and new targeted therapies for hematological malignancy
- (2019) Julian Lindsay et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Bridging antifungal prophylaxis with 50 mg or 100 mg micafungin in allogeneic stem cell transplantation: A retrospective analysis
- (2019) Achim Rothe et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole
- (2018) Caitlin R Rausch et al. CLINICAL INFECTIOUS DISEASES
- Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting?
- (2018) Monica Fung et al. CLINICAL INFECTIOUS DISEASES
- Arzneimitteltherapiesicherheit: Interaktionen – Endothelin- Rezeptorantagonisten
- (2018) Holger Petri Deutsches Arzteblatt International
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study
- (2018) David J. Epstein et al. JOURNAL OF INFECTION
- Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
- (2018) Courtney D DiNardo et al. LANCET ONCOLOGY
- Isavuconazole shortens the QTc interval
- (2018) Sibylle C. Mellinghoff et al. MYCOSES
- Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
- (2018) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ivosidenib: First Global Approval
- (2018) Sohita Dhillon DRUGS
- Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
- (2018) Randy A. Taplitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypomethylating agents in combination with venetoclax for acute myeloid leukemia: Update on clinical trial data and practical considerations for use
- (2018) Matthew Mei et al. AMERICAN JOURNAL OF HEMATOLOGY
- Acute myeloid leukemia: 2019 update on risk-stratification and management
- (2018) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
- (2018) Richard F. Schlenk et al. BLOOD
- Drug–drug interactions in patients receiving hematopoietic stem cell transplantation
- (2018) Ana Pejčić et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
- (2017) Oliver A Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Echinocandins in antifungal pharmacotherapy
- (2017) Akash Patil et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
- (2017) Richard M. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4
- (2017) Andreas H. Groll et al. Transplant Infectious Disease
- A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML
- (2016) Steven Knapper et al. BLOOD
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Increased inhibition of cytochrome P450 3A4 with the tablet formulation of posaconazole
- (2016) A. Petitcollin et al. Drug Metabolism and Pharmacokinetics
- Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients
- (2016) Silvia Park et al. JOURNAL OF INFECTION
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study
- (2015) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance inAspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
- (2015) Paul E. Verweij et al. CLINICAL INFECTIOUS DISEASES
- A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients
- (2015) Brenda W. Cooper et al. Clinical Lymphoma Myeloma & Leukemia
- Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice
- (2015) Vincent JC Lempers et al. CURRENT OPINION IN PHARMACOLOGY
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
- (2015) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
- (2013) R W F van Leeuwen et al. BRITISH JOURNAL OF CANCER
- Investigation into CYP3A4-mediated drug–drug interactions on midostaurin in healthy volunteers
- (2013) Catherine Dutreix et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Is there a role for statins in fungal infections?
- (2013) Peter W Bergman et al. Expert Review of Anti-Infective Therapy
- Liquid chromatography–tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis
- (2013) Philippe Bourget et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?
- (2013) M. Levis Hematology-American Society of Hematology Education Program
- Pharmacokinetics of Different Dosing Strategies of Oral Posaconazole in Patients with Compromised Gastrointestinal Function and Who Are at High Risk for Invasive Fungal Infection
- (2012) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
- (2012) J. J. Vehreschild et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and Safety of Current Drug Therapies for Invasive Aspergillosis
- (2011) Friederike Traunmüller et al. PHARMACOLOGY
- 4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
- (2010) Ulf Diczfalusy et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients
- (2010) L. Pagano et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
- (2010) Thomas Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Current experience in treating invasive zygomycosis with posaconazole
- (2009) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome
- (2009) Gloria N. Mattiuzzi et al. SUPPORTIVE CARE IN CANCER
- Numbers Needed to Treat with Posaconazole Prophylaxis to Prevent Invasive Fungal Infection and Death
- (2008) Oliver A. Cornely et al. CLINICAL INFECTIOUS DISEASES
- Aspergillus to Zygomycetes: Causes, Risk Factors, Prevention, and Treatment of Invasive Fungal Infections
- (2008) O. A. Cornely INFECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started